Response to characterization of orbital masses by multiparametric MRI

2016 ◽  
Vol 85 (9) ◽  
pp. 1686-1687
Author(s):  
A. Lecler ◽  
D. Balvay ◽  
L. Fournier
2016 ◽  
Vol 85 (2) ◽  
pp. 324-336 ◽  
Author(s):  
Sa-Ra Ro ◽  
Patrick Asbach ◽  
Eberhard Siebert ◽  
Eckart Bertelmann ◽  
Bernd Hamm ◽  
...  

JOR Spine ◽  
2020 ◽  
Vol 3 (2) ◽  
Author(s):  
David B. Berry ◽  
Ana E. Rodriguez‐Soto ◽  
Erin K. Englund ◽  
Bahar Shahidi ◽  
Callan Parra ◽  
...  

2017 ◽  
Vol 209 (2) ◽  
pp. 339-349 ◽  
Author(s):  
Andrei S. Purysko ◽  
Leonardo K. Bittencourt ◽  
Jennifer A. Bullen ◽  
Thomaz R. Mostardeiro ◽  
Brian R. Herts ◽  
...  

Author(s):  
Alexander P Cole ◽  
Bjoern J. Langbein ◽  
Francesco Giganti ◽  
Fiona M. Fennessy ◽  
Clare M. Tempany ◽  
...  

The role of multiparametric MRI in diagnosis, staging and treatment planning for prostate cancer is well established. However there remain several challenges to widespread adoption. One such challenge is the duration and cost the examination. Abbreviated exams omitting contrast enhanced sequences may help address this challenge. In this review, we will discuss the rationale for biparametric MRI (bpMRI) for detection and characterization of clinically significant prostate cancer prior to biopsy and synthesize the published literature. We will weigh up the advantages and disadvantages to this approach and lay out a conceptual cost/benefit analysis regarding adoption of bpMRI.


2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Daniel J. A. Margolis

Multiparametric MRI of the prostate combines high-resolution anatomic imaging with functional imaging of alterations in normal tissue caused by neoplastic transformation for the identification and characterization ofin situprostate cancer. Lesion detection relies on a systematic approach to the analysis of both anatomic and functional imaging using established criteria for the delineation of suspicious areas. Staging includes visual and functional analysis of the prostate “capsule” to determine ifin situdisease is, in fact, organ-confined, as well as the evaluation of pelvic structures including lymph nodes and bones for the detection of metastasis. Although intertwined, the protocol can be optimized depending on whether lesiondetectionorstagingis of the highest priority.


Author(s):  
Timo A. Auer

Key Points• The management of gliomas has changed dramatically since the presentation of the revised WHO Classification of Tumors of the Central Nervous System in 2016 emphasizing the tumor heterogeneity based on their molecular profile.• The need for a more noninvasive characterization of glioblastomas (GBM) by establishing reliable imaging biomarkers to predict patient outcome and improve therapy monitoring is bigger than ever.• Multiparametric MRI, including promising newer techniques like electrical property tomography and mapping, may have the potential to provide enough information for intelligent imaging postprocessing algorithms to face the challenge by decoding GBM heterogeneity noninvasively.


Sign in / Sign up

Export Citation Format

Share Document